MT-ATP6 and Leigh syndrome: The mitochondriopathy resulting from the mutation in gene MTATP6 has an extremely variable clinical phenotype including Leigh syndrome (LS), neurogenic muscle weakness, ataxia, retinitis pigmentosa (NARP), and occasionally asymptomatic patients [1].